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Summary
In many species, reducing nutrient intake without causing malnutrition extends lifespan [1-3]. Like
DR (dietary restriction), modulation of genes in the insulin-signaling pathway, known to alter nutrient
sensing, has been shown to extend lifespan in various species [1-4]. In Drosophila, the target of
rapamycin (TOR) and the insulin pathways have emerged as major regulators of growth and size.
Hence we examined the role of TOR pathway genes in regulating lifespan by using Drosophila. We
show that inhibition of TOR signaling pathway by alteration of the expression of genes in this
nutrient-sensing pathway, which is conserved from yeast to human, extends lifespan in a manner that
may overlap with known effects of dietary restriction on longevity. In Drosophila , TSC1 and TSC2
(tuberous sclerosis complex genes 1 and 2) act together to inhibit TOR (target of rapamycin), which
mediates a signaling pathway that couples amino acid availability to S6 kinase, translation initiation,
and growth [5]. We find that overexpression of dTsc1, dTsc2, or dominant-negative forms of dTOR
or dS6K all cause lifespan extension. Modulation of expression in the fat is sufficient for the lifespan-
extension effects. The lifespan extensions are dependent on nutritional condition, suggesting a
possible link between the TOR pathway and dietary restriction.
Introduction
A reduction in nutrient intake, also known as dietary restriction (DR), extends lifespan in
various species including worm (C. elegans), fly (D. melanogaster), yeast (S. cerevisiae), and
mouse (Mus musculus) [1,2]. Like DR, modulation of genes in the insulin-signaling pathway,
known to alter nutrient sensing, has been shown to extend lifespan in various species [1-4].
Evolutionary theory suggests that DR regulates certain genetic pathways that shift an
organism's metabolic investment from reproduction and growth toward somatic maintenance
[3,6,7], allowing the organism to survive under harsh environments until there are suitable
reproductive conditions. In C. elegans, in response to crowding and starvation, the insulin/
insulin-like growth factor (IGF-1) signaling pathway controls the formation of the dauer larva,
an alternative developmental state that is nonreproducing, stress resistant, and long lived [8,
9]. Mutations in genes of the same pathway, daf-2 (insulin receptor) and age-1 (Phosphatidyl
inositol-3 kinase), lead to a doubling of lifespan, and render the animals more sensitive to dauer
formation [10]. Both the dauer-formation and lifespan-extension phenotypes are suppressed
by mutations in daf-16, a forkhead family transcription factor [10,11]. Drosophila mutations
in Inr (insulin-like receptor) and chico (insulin-receptor substrate), both components of the
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insulin-signaling pathway, also regulate lifespan [12,13]. A reduction of nutrients in the fly
diet has been shown to extend lifespan in the fly [14-16]. Reduced availability of protein or
yeast in the fly diet can reduce signaling through the InR/PI3K pathway, as measured by using
a pleckstrin homology domain green fluorescent protein (PH-GFP), which is localized to the
cell membrane when the PI3K pathway is active [17]. Furthermore, the lifespan extension that
is observed by chico mutant flies is dependent on the nutritional content of fly food, suggesting
an overlap between the two mechanisms of lifespan extension [14].
In Drosophila, nutrient availability and insulin signaling have been shown to be critical factors
in regulating not only lifespan but also growth and size [18]. Inhibition of InR/PI3K signaling,
by using mutations in the pathway, phenocopies the cellular and organismal effects of
starvation, leading to a reduction in the size of the fly [17,19,20]. Tsc1, Tsc2, TOR, and S6
kinase have emerged as important regulators of growth and size in Drosophila in a pathway
that is parallel to, but also interactive with, the insulin pathway (Figure S1) [21]. Recent
evidence suggests that the fat body in Drosophila acts as a nutrient sensor, which uses TOR
signaling to generate a humoral signal that modulates insulin signaling and growth in peripheral
tissues [22]. TOR deficiency in the nematode C. elegans was recently shown to extend lifespan
[23]. We therefore tested whether modulating the activities of genes in the TOR pathway might
regulate lifespan.
Results and Discussion
The Drosophila homologs of human Tsc1 (Hamartin) and Tsc2 (tuberin) function in vivo as
a complex that controls growth and size in a cell-autonomous manner [24-27]. To examine
their role in regulating lifespan, we overex-pressed dTsc1 and dTsc2 by using constructs
provided by the Duojia Pan lab [5] through the ubiquitously expressed driver, daughterless
(da)-GAL4. We found that overexpression in transgenic flies carrying UAS constructs
containing dTsc1 or dTsc2 extended mean lifespan at 29°C by 14% and 12%, respectively
(Figures 1A and 1B). Since GAL4 enhancer traps generally yield stronger effects at 29°C, we
chose to perform most of the experiments at that temperature [28].
dTsc1 and dTsc2 physically interact with dTOR [5], which is conserved from yeast to human
as a nutrient sensor [18]. Loss of dTsc1 in Drosophila eye leads to an increase in cell size,
provided that dTOR is present [5]. Surprisingly, however, dTOR overexpression causes a
reduction in cell size, a phenotype similar to dTOR loss-of-function mutations, perhaps due to
titration of cofactors required for TOR signaling [29]. We examined the effect of dTOR on
lifespan by using three UAS constructs generously provided by the Thomas Neufeld lab [29].
One carries the full-length wild-type TOR gene. The second carries FRB, the 11 kDa FKBP12-
rapamycin binding domain, which has been shown to prevent S phase entry when injected into
human osteosarcoma cells [30]. The third carries TED (toxic effector domain), containing the
754 amino acid central region, which inhibits cell growth and arrests cells in G1 when
overexpressed in yeast [29]. Ubiquitous overexpression with the da-GAL4 driver of UAS-
dTORFRB led to a mean life-span increase at 29°C of 24% (Figure 1C). However,
overexpression of UAS -dTORWT or UAS-dTORTED prevented eclosion to adulthood (data not
shown).
S6 kinase activation upon phosphorylation has been implicated in mediating the downstream
effects of TOR on translation initiation in flies and mammals [21]. S6 kinase phosphorylation
of ribosomal protein S6 is accompanied by upregulation of a class of mRNAs containing an
oligopyrimidine tract at their transcriptional start site termed 5′TOP [31]. Some 200 genes,
most of which encode components of the translational apparatus including ribosomal proteins
and elongation factors, have this sequence and can account for about 20% of total cellular
mRNA [31]. Flies carrying homozygous mutations in dS6K show a developmental delay and
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a reduction in body size [32]. The stimulation of dS6K phosphorylation by dTOR is abrogated
when dTsc1 and dTsc2 are overexpressed [5]. Furthermore, flies with reduced dTSC1 show
increased dS6 kinase activation, and genetic reduction of S6 kinase level can rescue the lethality
caused by loss of function of dTsc1 [33].
We examined the role of S6 kinase in regulating life-span by using dominant-negative and
constitutively active constructs generously provided by the Mary Stewart lab [34]. The
dominant-negative effect was achieved by replacing the conserved lysine in the ATP binding
site by glutamine (UAS-dS6KKQ), which causes cell-size reduction. The constitutively active
form was generated by replacing the phosphorylation sites of S6 kinase by acidic amino acids
(UAS-dS6KSTDETE), causing an autonomous cell size increase [34]. By using da-GAL4 to
drive ubiquitous overexpression of the dominant-negative form, we observed a mean lifespan
increase of 22% at 29°C (Figure 1D). Conversely, overexpression of the constutively active
form of S6 kinase caused a mean lifespan decrease of 34% at 29°C (Figure 1E). Overexpression
of dTsc2 and dTORFRB was also tested at 25°C and led to a 20% and 26% increase in mean
lifespan increase, respectively (Figures 1F and 1G).
To determine which tissues are responsible for the lifespan extension, we employed various
GAL4 drivers with specific GAL4 expression pattern (Figure S2) to overexpress dTsc2 via a
UAS promoter. Overexpression in the eye by using the driver gmr-GAL4 or in the nervous
system by using appl-GAL4 did not extend lifespan (Figures 2A and 2B). On the other hand,
by using the drivers 24B-GAL4 and PO188-GAL4, enhancer traps that are predominantly
expressed in the muscle and fat resulted in mean lifespan extensions of 27% and 37%,
respectively, at 29°C (Figures 2C and 2D). The fat-specific drivers DJ634-GAL4 and PO163-
GAL4, when used to over-express dTsc2, also led to a mean lifespan extension of 22% and
31%, respectively, at 29°C (Figures 2E and 2F). Using DJ634-GAL4 to overexpress the
dominant-negative form of TOR (UAS-dTORFRB) or of S6 kinase (UAS-UAS-dS6KKQ) also
led to mean lifespan increases of 30% and 29%, respectively, at 29°C (Figures 2G and 2H).
These results indicate that manipulation of the TSC, TOR, and S6 kinase genes in the fat tissue
is sufficient for their lifespan extension effects in Drosophila.
Amino acids have been shown to activate dS6k via TOR, an effect that can be abrogated in the
presence of increased levels of dTsc1 and dTsc2 [5]. As nutrients in the diet can modulate
lifespan and because the TOR pathway is a critical mediator of nutrient signaling, we asked
whether the observed lifespan-extension effects are dependent on nutrient conditions. We
tested this with overexpression of dTsc2 by using the ubiquitously expressing da-GAL4 driver.
Flies were allowed to develop to adulthood under standard laboratory food and then maintained
on specially prepared food containing various concentrations of yeast extract. At high
concentrations of yeast extract, which may be regarded as the opposite of dietary restriction,
the lifespan of control flies (da-GAL4/+) was severely reduced (Figure 3). However,
overexpression of dTsc2 protects the fly from the deleterious effects of rich food, as if
mimicking the effect of dietary restriction (Figure 3). Similar results were observed by
overexpression of the dominant-negative form of S6 kinase (data not shown).
Recent evidence from Drosophila suggests that signaling through TSC is both parallel to and
interacting with the insulin pathway [21,25]. This is supported by the finding that
heterozygosity of dTsc1 or dTsc2 is sufficient to rescue the lethality of loss-of-function dInR
mutants [25]. However, the finding that loss-of-function mutations of dTsc1 and dPTEN, a
phosphatase that negatively regulates the insulin-signaling pathway, cause cell autonomous
and additive increases in cell size suggests that they may be in parallel pathways [25].
Furthermore, in Drosophila, dPTEN loss of function, which leads to an increase in cell size,
is only slightly suppressible by loss of function of dFOXO, a fly homolog of C. elegans
daf-16 [35]. However, the increase in cell size resulting from dTsc1 is enhanced by dFOXO
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loss of function [35]. Interestingly, unlike long-lived daf-2 mutants, the lifespan extension due
to TOR deficiency in C. elegans is not suppressible by a daf-16 mutation [23]. However, the
TOR mutant animals do not further extend lifespan in a daf-2 background, leading to the
possibility that TOR may be acting downstream or separately from daf-16 to exert its lifespan
effects [23].
Lifespan extension has been linked with other phenotypes, including stress resistance,
metabolic rate, lipid level, reproductive capacity, and body size [16,36,37]. We compared the
long-lived strains described above with their respective controls for resistance to starvation but
found no significant differences (Table S1). Similarly, no significant differences were observed
for weight and lipid content among these strains (Table S1). It may be that lifespan extension
can be produced by mild modulation of these genes, whereas effects on other phenotypes
require severe perturbations. While lifespan extension is observed by using the da-GAL4 driver
to overexpress dTsc1 or dTsc2 alone, simultaneous overexpression of dTsc1 and dTsc2
prevented eclosion to adulthood (data not shown). Similarly, no change in size is observed if
dTsc1 or dTsc2 alone are overexpressed in the eye, but a cell-autonomous decrease in size is
seen when both are overexpressed simultaneously [25,26]. Lifespan extension by chico is
semidominant, but its effect on body size is recessive [13]. Dominant effects on lifespan are
observed with the genes Inr, EcR, Indy, and Rpd3, but their effects on lifespan can be uncoupled
from other phenotypes such as fecundity, stress resistance, or lipid accumulation.
In humans, mutations in TSC1 and TSC2 lead to tuberous sclerosis, a common disorder
characterized by the presence of benign tumors in various tissues, with some having large cells.
DR in mice has been shown to protect against age-related tumorigenesis [38,39]. Our results
suggest a link between lifespan extension by DR and the activities of genes in the TOR pathway.
Hence, it is conceivable that the protective effects of DR on tumori-genesis and age-related
decline might come from inhibition of such nutrient-responsive pathways.
Our results show that upregulation of dTsc2 in the fat is sufficient for lifespan extension effects
in Drosophila. Reduction of daf-2 levels in the C. elegans nervous system has been shown to
be sufficient for lifespan extension [40,41]. However, the lifespan extensions due to mutations
in the insulin pathway or germline ablation in C. elegans are dependent on daf-16 activity in
the intestine, the fat storage tissue in C. elegans [41]. In Drosophila, the fat body has been
proposed to modulate insulin signaling in peripheral tissues by secretion of dALS (acid-labile
subunit) [22], which, in mammals, forms a ternary complex with insulin-like growth factor,
leading to an extension of the half-life of its ligand [42]. Recently, mice with FIRKO (fat-
specific insulin receptor knockout) have been shown to live 18% longer than controls [43].
Hence, it is possible that secondary endocrine signals downstream of the insulin and TOR
signaling pathways are released from the fat, and these affect the rate of aging in other tissues.
Juvenile hormone and ecdysone are two such endocrine signals that have been implicated in
regulating lifespan in conjunction with the insulin pathway in Drosophila [4].
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Figure 1. Regulation of Lifespan by Modulating Genes in the TOR Signaling Pathway
Survival curves on standard laboratory food for male flies obtained after crossing the
ubiquitously expressed da-GAL4 enhancer trap with various UAS constructs carrying genes
in the TOR signaling pathway ([A]–[E] at 29°C, [F] and [G] at 25°C). All logrank test p values
are based on comparison of the overexpressor strain with the driver alone. The plus symbol
indicates the parental strain w1118. The mean lifespan (days) of the various genotypes were as
follows. (A) da-GAL4/UAS-dTsc1 (closed squares), 29 days (n=136); +/da-GAL4 (driver
alone) (open triangles), 26 days (n = 92); +/UAS-dTsc1 (open circles), 25 days (n = 109) (p <
0.0001). (B) da-GAL4/UAS-dTsc2 (closed squares), 29 days (n = 112); +/da-GAL4 (open
triangles), 26 days (n = 92); +/UAS-dTsc2 (open circles), 25 days (n = 118) (p < 0.0001). (C)
da-GAL4/UAS-dTORFRB (closed squares), 30 days (n = 126); +/da-GAL4 (open triangles),
26 days (n = 92); +/UAS-dTORFRB (open circles), 22 days (n = 98) (p < 0.0001). (D) da-GAL4/
UAS-dS6kKQ (closed squares), 30 days (n = 122); +/da-GAL4 (open triangles), 26 days (n =
92); +/UAS-dS6kKQ (open circles), 23 days (n = 115) (p < 0.0001). (E) da-GAL4/UAS-
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dS6kSTDETE (closed squares), 16 days (n = 75); +/da-GAL4 (open triangles), 26 days (n = 92);
+/UAS-dS6kSTDETE (open circles), 24 days (n = 40) (p < 0.0001). (F) da-GAL4/UAS-dTsc2
(closed squares), 69 days (n = 134); +/da-GAL4 (open triangles), 58 days (n = 133); +/UAS-
dTsc2 (open circles), 56 days (n = 126) (p < 0.0001). (G) da-GAL4/UAS-dTORFRB (closed
squares), 72 days (n = 112); +/da-GAL4 (open triangles), 58 days (n = 133); +/UAS-
dTORFRB (open circles), 55 days (n = 128) (p < 0.0001).
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Figure 2. Dependence of Lifespan Extension on Overexpression in Specific Tissues
Survival curves, on standard laboratory food, for male flies obtained by crossing various genes
in the TOR pathway by using different tissue specific drivers along with appropriate control
strains. gmr-GAL4 is expressed in the eye, appl-GAL4 in the nervous system, 24B-GAL4 and
PO188-GAL4 in the muscle and fat tissues, and DJ634-GAL4 and PO163-GAL4 in the fat
tissue. All logrank test p values were based on comparison of the overexpressor strain with the
driver alone. The plus symbol indicates the parental strain w1118. The mean lifespan at 29°C
of the various genotypes were as follows. (A) gmr-GAL4/ UAS-dTsc2 (closed squares), 27
days (n = 69); +/gmr-GAL4 (open triangles), 31 days (n = 102); +/UAS-dTsc2 (open circles),
27 days (n = 81) (p < 0.01). (B) appl-GAL4/ UAS-dTsc2 (closed squares), 33 days (n = 108);
+/appl-GAL4 (open triangles), 32 days (n = 85); +/UAS-dTsc2 (open circles), 27 days (n =
81) (p < 0.001). (C) 24B- GAL4/UAS-dTsc2 (closed squares), 37 days (n = 107); +/24B-GAL4
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(open triangles), 31 days (n = 67); +/UAS-dTsc2 (open circles), 27 days (n = 81) (p < 0.0001).
(D) PO188-GAL4/UAS-dTsc2 (closed squares), 35 days (n = 76); +/PO188-GAL4 (open
triangles), 24 days (n = 71); +/ UAS-dTsc2 (open circles), 27 days (n = 81) (p < 0.0001). (E)
DJ634-GAL4/UAS-dTsc2 (closed squares), 30.6 days (n = 120); +/DJ634-GAL4 (open
triangles), 24.6 days (n = 120); +/UAS-dTsc2 (open circles), 25.3 days (n = 118) (p < 0.0001).
(F) PO163-GAL4/UAS-dTsc2 (closed squares), 36 days (n = 126); +/PO163-GAL4 (open
triangles), 28 days (n = 87); +/UAS-dTsc2 (open circles), 27 days (n = 81) (p < 0.0001). (G)
DJ634-GAL4/UAS-dTORFRB (closed squares), 31 days (n = 107); +/DJ634-GAL4 (open
triangles), 25 days (n = 120); +/UAS-dTORFRB (open circles), 22 days (n = 98) (p < 0.0001).
(H) DJ634-GAL4/UAS-dS6kKQ (closed squares), 31 days (n = 110); +/DJ634-GAL4 (open
triangles), 25 days (n = 120); +/UAS-dS6kKQ (open circles), 23 days (n = 115) (p < 0.0001).
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Figure 3. Lifespan Extension by dTsc2 Overexpression Is Dependent on the Concentration of Yeast
Extract in the Diet
Logrank test was used to calculate the p values. The plus symbol indicates the parental strain
w1118. Mean lifespan at 29°C of adult male da-Gal4/+ (closed triangles) and da-GAL4/UAS-
dTSC2 (closed squares) flies were: on 0.1% yeast extract, da-Gal4/+, 33 days (n = 125) and
da-GAL4/UAS-dTSC2, 30 days (n = 164); on 0.3% yeast extract, da-Gal4/+, 31 days (n = 139)
and da-GAL4/UAS-dTSC2, 33 days (n = 138); on 1% yeast extract, da-Gal4/+, 30 days (n =
182) and da-GAL4/UAS-dTSC2, 34 days (n = 164); on 3% yeast extract, da-Gal4/+, 28 days
(n = 181) and da-GAL4/UAS-dTSC2, 34 days (n = 154); on 9% yeast extract, da-Gal4/+, 12
days (n = 150) and da-GAL4/UAS-dTSC2, 24 days (n = 156). Mean lifespan differences
between flies overexpressing dTsc2 and controls were −9% (p < 0.3), +5% (p < 0.03), +13%
(p < 0.0001), +23% (p < 0.0001), and 95% (p < 0.0001) when lifespan was measured on fly
food containing 0.1%, 0.3%, 1%, 3%, and 9% yeast extract, respectively.
Kapahi et al. Page 11
Curr Biol. Author manuscript; available in PMC 2009 September 30.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
